The effects of quercetin on lipid profile, inflammatory biomarkers and ACE2 in a dyslipidaemic rabbit model.

Quercetin demonstrated lipid-lowering effects, particularly on total and LDL cholesterol, in a rabbit model of dyslipidaemia. However, it did not significantly affect systemic inflammatory or enzymatic markers. These findings suggest potential lipid-lowering effects independent of inflammation. While quercetin was not superior to atorvastatin, it shows promise as a natural adjunct or alternative therapy.